These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15120877)

  • 1. Statins in patients at high risk of cardiovascular disease presenting with peripheral artery disease.
    Boland B; Goderis G
    Eur Heart J; 2004 May; 25(9):712-3. PubMed ID: 15120877
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
    Coppola G; Novo S
    Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of statins on renal function in patients with peripheral arterial disease.
    Paraskevas KI; Bessias N; Tzorbatzoglou J; Mikhailidis DP; Andrikopoulos V
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):620-1; author reply 621. PubMed ID: 19056802
    [No Abstract]   [Full Text] [Related]  

  • 5. Have statins changed the natural history of atheromatous disease and its treatment?
    Samson RH
    Semin Vasc Surg; 2008 Sep; 21(3):160-4. PubMed ID: 18774452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral arterial procedures and postinterventional prophylaxis.
    Kröger K
    J Endovasc Ther; 2006 Feb; 13(1):32-8. PubMed ID: 16445321
    [No Abstract]   [Full Text] [Related]  

  • 7. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How many claudicants should be prescribed statins?
    Harrison EM; Holdsworth RJ
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal medical management of peripheral arterial disease.
    Paraskevas KI; Hamilton G; Mikhailidis DP; Liapis CD
    Vasc Endovascular Surg; 2007; 41(1):87. PubMed ID: 17277251
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of statins in reversing atherosclerosis: what the latest regression studies show.
    Grines CL
    J Interv Cardiol; 2006 Feb; 19(1):3-9. PubMed ID: 16483333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 12. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease.
    Schillinger M; Exner M; Mlekusch W; Amighi J; Sabeti S; Muellner M; Rumpold H; Wagner O; Minar E
    Eur Heart J; 2004 May; 25(9):742-8. PubMed ID: 15120884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins in stroke prevention].
    Gedikli O; Baykan M
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):217-22. PubMed ID: 18524729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pleiotropic effects of statins].
    Westerweel PE; Verhaar MC; Rabelink TJ
    Ned Tijdschr Geneeskd; 2004 Jul; 148(29):1431-5. PubMed ID: 15326645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of statin drugs in the management of the peripheral vascular patient.
    Samson RH
    Vasc Endovascular Surg; 2008; 42(4):352-66. PubMed ID: 18621887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dyslipidemia with statins in the patient with peripheral arterial disease.
    Blum AS
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):50-5. PubMed ID: 17482100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN; Modrall JG
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and age-related macular degeneration: time for a randomized controlled trial?
    Wong TY; Rogers SL
    Am J Ophthalmol; 2007 Jul; 144(1):117-9. PubMed ID: 17601430
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol and peripheral vascular disease: a neglected topic?
    Atar D; Jørgensen JJ
    Scand Cardiovasc J; 2007 Jun; 41(3):136-7. PubMed ID: 17487760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.